Recovery from COVID-19 infection
Conditions
Interventions
experimental group:According to the type of syndrome, the subjects were given Gubenfuyuan granule and Sanshen Laifu respectively Granule or Shenling Fukang granule.
control group:At the same time, simulants with the same packaging, dosage form, color and smell as the "three medicines" are applied.
Sponsors
The Affiliated Hospital of Hunan Academy of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Age = 18 years old =75 years old (without any co-morbidity, age can be relaxed to 80 years old and below), both male and female; 2. Patients who meet the diagnostic criteria for the convalescence period of COVID-19 infection; 3. Those who meet the diagnostic criteria of lung, spleen and kidney deficiency, Qi and Yin deficiency syndrome, spleen and lung Qi deficiency syndrome; 4. Can provide contact details, no short-term migration intention, can be willing to cooperate with the visitor; 5. Voluntarily participate and sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with severe hepatic and renal insufficiency (severe hepatic insufficiency is defined as ALT >2 times the upper limit of normal or AST >2 times the upper limit of normal; Severe renal insufficiency is defined as Cr value >1.5 times the upper limit of normal); 2. Severe pulmonary dysfunction [FEV1 % of expected value (including obstruction or limitation) : severe: 35% ~ 49%; extremely severe: <35%; or DLCO % of expected value: <40%; or for all measures, use Z-value: severe: <-4.1]; 3. Patients with diseases of blood, immune and tumor systems; 4. Pregnant or breastfeeding; 5. Test drug contraindications and allergies; 6. Participants in other clinical trials in the last 3 months; 7. Persons with serious mental illness; 8. Patients with a history of drug rash or allergic reaction to drugs; 9. People who are currently infected with influenza viruses such as swine flu and are taking antiviral drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Therapeutical effective rate;Total clinical symptom scores; | — |
Secondary
| Measure | Time frame |
|---|---|
| FAS Fatigue Rating Scale;VAS Pain Visual Analogue Scale;SF-36 Health Survey Scale;TCM syndrome score; | — |
Countries
China
Contacts
Public ContactGe Jinwen Wu DAhua
Hunan Academy of Traditional Chinese Medicine
Outcome results
None listed